---
title: "Changshan Pharmaceutical Shares Trigger Abnormal Trading Alert After Three-Day Drop"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290024696.md"
description: "Changshan Pharmaceutical issued an announcement regarding abnormal stock volatility after its shares fell over 30% in three days. The company clarified that the regulatory review for its ebronatide injection, a type 2 diabetes treatment, is ongoing with no definitive approval conclusion yet. Additional materials are being submitted to the National Medical Products Administration, and both the outcome and timeline remain uncertain."
datetime: "2026-06-17T08:42:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290024696.md)
  - [en](https://longbridge.com/en/news/290024696.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290024696.md)
generator: "portal-rs"
---

# Changshan Pharmaceutical Shares Trigger Abnormal Trading Alert After Three-Day Drop

Changshan Pharmaceutical issued an announcement on unusual share-price movements after its stock recorded a cumulative closing-price deviation decline of more than 30% over three consecutive trading days, meeting the Shenzhen Stock Exchange’s criteria for abnormal trading volatility. According to Jin10, the company said its marketing authorization application for its ebronatide injection, intended to treat type 2 diabetes, remained under regulatory review. Changshan Pharmaceutical said it was submitting additional materials in line with requirements from the Center for Drug Evaluation under China’s National Medical Products Administration, and the review had not yet been completed. The company said there was currently no definitive conclusion on whether the product would be approved for listing. It added that both the final review outcome and the timing for completion of the review remained uncertain.

### Related Stocks

- [300255.CN](https://longbridge.com/en/quote/300255.CN.md)

## Related News & Research

- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [REG - RentGuarantor Hldgs - TR-1: Notification of major holdings](https://longbridge.com/en/news/297805070.md)
- [Germany approves tax cuts for families, partly funded by top earners](https://longbridge.com/en/news/297777724.md)
- [03:26 ETZoomlion Strengthens European Localization through Expanded Service, Manufacturing, and Technology Collaboration](https://longbridge.com/en/news/297613028.md)
- [Nexstim receives order for additional NBS 6 therapy system from Nordic private clinic](https://longbridge.com/en/news/297867104.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**